• Blog
  • News
  • All services
  • EN
  • EN
  • +34 91 277 10 76
  • info@azierta.com
logo
  • Azierta
    • About Us
    • Meet Our Team
    • Contact us
  • Services
    • Pharmacovigilance
      • ICSR Management
      • EudraVigilance Registration & Support
      • XEVMPD, Art. 57
      • Safety Reports
      • Signal Detection
      • QPPV support
      • Pharmacovigilance Quality system
      • PSMF and Pharmacovigilance agreements
      • Vigilazierta: Safety database
    • Regulatory Affairs
      • Products registration
      • Dossiers compilation
      • Post-authorization support
      • IDMP – Identification of Medicinal Products
    • GxP Compliance & Safety
      • Toxicological Evaluation of Impurities and Risk Analysis
      • Toxicology reports
      • Biosafety Support
      • REACH Compliance Support- CLP
      • GxP Support: Advice & Implementation of Quality Systems
      • ISO Compliance Support
      • Medical Cannabis Consultancy
    • Digital, Science & Growth
      • Digital Strategy
      • Content Marketing
      • Software Solutions
      • Data & Analytics
    • Audit & Certification
      • GxP Audits
      • Supplier Audit Reports
      • Clinical Analysis Laboratories Audits
      • Audits for Compliance of Medical Devices
      • Medical Cannabis Audits
      • Data Integrity Audits
      • Internal Audits
    • Azierta Care
      • Cosmetics
      • Food Supplements
      • Medical Devices
    • Strategy & Intelligence
      • Life Science Investment Consulting
      • Life Science Business Development
      • Next Generation Regulatory Intelligence
      • Translational Medicine and Clinical Development
      • Next-generation Medical Affairs
  • Integrated Programs
    • Animal Health
    • Biopharma
    • Quality Management System
    • Landing in Europe
    • Medical Cannabis
    • Replace Titanium dioxide
    • Vigilazierta: Safety Database
  • Careers
    • Azierta Associates
  • Academy
  • Contact Us
  • e-Consulting
e-Consulting
logo
logo

thc

  • Home  
  • thc
medical cannabis azierta
All Cannabis
  • August 17, 2021
  • /
  • By azierta
  • /
  • 0 Comments

The Spanish Congress has created a subcommission to study the regulation of the medicinal use of cannabis

Marta Rodríguez Vélez | GXP Compliance & Safety Director | AZIERTA – July 2021   During the plenary session of the Spanish Parliament held on 10th June 2021 the constitution of the Health Subcommission was approved to study the regulation of the medicinal use of cannabis. This application is aimed at “analysing experiences of regulation […]

READ MORE

Search

Categories

  • All
  • Animal Health
  • Audit & Certification
  • Azierta
  • Cannabis
  • Cosmetics
  • Food Supplements
  • GxP Compliance & Safety
  • Landing in Europe
  • Medical Devices
  • News
  • Pharmacovigilance
  • Quality
  • Regulatory Affairs
  • Toxicology

Latest posts

  • Main Changes revision ICH Q3D (R2) on elemental impurities guideline
  • Azierta has attended Food 4 Future 2022
  • Inorganic impurities
  • Azierta attending at Vitafoods Europe
  • Azierta Care and the importance of diversifying markets

Contact Details

  • Call Us : +34 91 277 10 76
  • Mail us : info@azierta.com

Recent Post

June 19, 2022

Main Changes revision ICH Q3D (R2) on elemental impurities guideline

Read More from Blog

Company certified By:

Azierta´s certifications
© 2022 Azierta Contract Science Support Consulting, All Rights Reserved.
    Cookies policy | Privacy policy | Quality policy | Legal Notice